Kamada Ltd 's (KMDA) Outlook - CSIMarket
CSIMarket
 
Kamada Ltd   (NASDAQ: KMDA)
 



  Kamada Ltd Outlook

On March 6 2024 the Kamada Ltd provided following guidance

Kamada Ltd., a global biopharmaceutical company, has reported strong financial results for both the fourth quarter and fiscal year of 2023. The company has shown significant growth in revenue and profitability, with double-digit increases expected for the full year of 2024.

Based on the latest estimates provided on March 6, 2024, Kamada Ltd. has demonstrated its success as a leader in the specialty plasma-derived field. The company's portfolio of marketed products for rare and serious conditions has contributed to its robust performance in the biopharmaceutical industry.

Kamada's presence in the market, both on the NASDAQ and TASE, reflects its status as a commercial stage company with a strong foundation for continued growth. The company's financial results for the year ended December 31, 2023, indicate a positive outlook for the future.

With guidance showing double-digit growth in revenue and profitability for the full year of 2024, Kamada Ltd. is well-positioned for continued success and expansion in the biopharmaceutical sector. Investors can expect continued strong performance from Kamada as the company capitalizes on its position as a key player in the global market.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.